Results 11 to 20 of about 105,036 (275)
Patents associated with high-cost drugs in Australia. [PDF]
PLoS ONE, 2013 Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by "evergreening" blockbuster drugs, through misuse of the patent ...
Andrew F Christie +4 more
doaj +1 more source
AI-driven molecular generation of not-patented pharmaceutical compounds using world open patent data
Journal of Cheminformatics, 2023 Developing compounds with novel structures is important for the production of new drugs. From an intellectual perspective, confirming the patent status of newly developed compounds is essential, particularly for pharmaceutical companies.
Yugo Shimizu +6 more
doaj +1 more source
Globalization and Health, 2018 Background Despite the significant impact of pharmaceutical innovations on healthcare, our understanding is still limited because previous studies explored only a few cases and largely came from a linear perspective.
Qiaolei Jiang, Chunjuan Luan
doaj +1 more source
Pharmaceutics, 2021 We present a data-driven approach to unveil the pharmaceutical technologies of cyclodextrins (CDs) by analyzing a dataset of CD pharmaceutical patents.
Juliana Rincón-López +3 more
doaj +1 more source
Pravo, 2021 In recent years, public health systems in high-income countries have been heavily exposed to pressures due to high drug prices. High drug prices are affected by market monopolies that pharmaceutical companies have thanks to patents, i.e.
Sonja Lučić
doaj +1 more source
The Journal of Qazvin University of Medical Sciences, 2020 Today, along with the relative expansion of public health around the world, various diseases such as AIDS, malaria, etc. are increasing in human societies. In this regard, the pharmaceutical industry is one of the most important industries that should be
Somayeh Rahmani +2 more
doaj +1 more source
Pharmaceutical Innovations: Superior Position of the USA and Weaknesses of German Research
Wirtschaftsdienst, 2021 The innovative strength of research performance is often measured in terms of inputs such as research funds or outputs such as patent applications. We present a novel indicator of pharmaceutical innovativeness that focuses on global medical breakthroughs
Andreas Eckert, Wolfgang Maennig
doaj +1 more source
TRIPS implementation and secondary pharmaceutical patenting in Brazil and India [PDF]
, 2015 This article compares national approaches toward secondary pharmaceutical patents. Because secondary patents can extend periods of exclusivity and delay generic competition, they can raise prices and reduce access to medicines. Little is known about what
Sampat, Bhaven N., Shadlen, Kenneth C.
core +2 more sources
Molecules, 2022 Acacia seyal is an important source of gum Arabic. The availability, traditional, medicinal, pharmaceutical, nutritional, and cosmetic applications of gum acacia have pronounced its high economic value and attracted global attention.
Mohamed A. Ashour +5 more
doaj +1 more source
Journal of Multidisciplinary Healthcare, 2021 Kazunari Sugimitsu,1,2 Yoshinobu Manome2 1Graduate School of Innovation Management, Kanazawa Institute of Technology, Tokyo, Japan; 2Core Research Facilities, Jikei University School of Medicine, Tokyo, JapanCorrespondence: Kazunari SugimitsuGraduate ...
Sugimitsu K, Manome Y
doaj